|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
AstraZeneca buys Omthera Pharma to bolster its cardiovascular drug business.
Stock futures point to a rebound Tuesday amid expectations of improved economic data and a spike in merger deals.
Tiffany is expected by analysts to report on Tuesday first-quarter earnings of 52 cents a share.
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.